On the contrary, other authors described controversial pro‐invasive effects of anti‐VEGF therapies that could depend on drug‐specific side‐effects on tumor microenvironment more than on the blockade of VEGF pathway (Chung et al, 2012; Singh et al, 2012). The gene discussed is VEGFA; the disease is neoplasm.